about
Branched-chain amino acids for people with hepatic encephalopathyTranexamic acid for upper gastrointestinal bleedingBranched-chain amino acids for people with hepatic encephalopathyBanding ligation versus beta-blockers for primary prevention in oesophageal varices in adultsCyclosporin versus tacrolimus for liver transplanted patientsAssociation of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?Effects of lixisenatide on elevated liver transaminases: systematic review with individual patient data meta-analysis of randomised controlled trials on patients with type 2 diabetesSafety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathyMortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysisBenefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-AnalysisReported methodologic quality and discrepancies between large and small randomized trials in meta-analysesInfection increases mortality in necrotizing pancreatitis: A systematic review and meta-analysis.The effect of a glucagon-like peptide-1 receptor agonist on glucose tolerance in women with previous gestational diabetes mellitus: protocol for an investigator-initiated, randomised, placebo-controlled, double-blinded, parallel intervention trialNon-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.Effects of adding ribavirin to interferon to treat chronic hepatitis C infection: a systematic review and meta-analysis of randomized trials.Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials.Systematic review: tranexamic acid for upper gastrointestinal bleeding.Evidence based diagnosticsLarge variations in risk of hepatocellular carcinoma and mortality in treatment naïve hepatitis B patients: systematic review with meta-analysesBenzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy.Meta-analysis: isosorbide-mononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices.Misuse of randomization: a review of Chinese randomized trials of herbal medicines for chronic hepatitis B.A 25-year-old woman with type 2 diabetes and liver disease.Artificial and bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group Protocol.Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studies.Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies.The effects of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes: protocol for a systematic review with meta-analysis of randomised trialsElevated liver enzymes, anaemia and osteopaenia in a young womanAgreement between reported use of interventions for liver diseases and research evidence in Cochrane systematic reviews.Bias in clinical intervention research.Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis.Associations between postprandial insulin and blood glucose responses, appetite sensations and energy intake in normal weight and overweight individuals: a meta-analysis of test meal studies.Banding ligation versus beta-blockers as primary prophylaxis in esophageal varices: systematic review of randomized trials.Antiviral therapy for prevention of hepatocellular carcinoma and mortality in chronic hepatitis B: systematic review and meta-analysisMeta-analyses on viral hepatitis.Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome.Hepato-biliary clinical trials and their inclusion in the Cochrane Hepato-Biliary Group register and reviews.Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials.
P50
Q24187134-B3ABE8FF-6B5A-4D7C-A2E1-5E3577F94FEDQ24187888-1280E74B-5FF1-4A8C-BDD2-742AEC574DD6Q24187960-CBBB11EE-D756-4181-848D-FF09BE2E8FACQ24201710-912313A3-6AED-489B-8D87-B94A6A71BB3DQ24244114-BE6BF9DC-CB26-4C06-88A2-A1DFD2229476Q26701411-0DF50C08-3CF5-401B-BCBB-7F6200119F58Q27025423-5B7FD601-B8F6-4551-91FA-4AED2F65DB54Q28236913-BE8C4F98-D229-4005-8BBC-4B337AF26758Q28290519-DFCAEA37-D769-4AE1-92C3-6F8132031E51Q28553482-F5BCBDB8-2934-40E5-B151-F89E39FB1789Q29619185-A3841281-4CF1-4A6F-8A03-2132EE6A0540Q30248827-C9C1157D-5C11-4D63-B02B-BA0A63B3FB6DQ30556651-5C959576-DAAA-4B0B-A306-3EBC093C51C4Q33200604-9FE05B0F-7A15-4145-B3B5-103BB59CE62EQ33225877-6B6B28BB-E26D-4BCD-9216-9B469E01C65AQ33234511-DEA69CFE-D196-44F1-9381-FECC05F15F06Q33318123-C9C58092-F20F-40F5-9A49-26A87AB9FE36Q33934950-DFC5425F-0F53-4687-9B25-2C3151FC8DCCQ34203972-CB13AC12-624E-4314-8DAA-7EA919145F3FQ34424783-5B066015-1E5D-4F6B-89E0-15DD9B7DC8F8Q34623430-A9B90194-2E91-4E88-80FD-E473721F3142Q34687478-BD64C3E1-D507-43E9-92C4-845EECC43697Q34975050-EEF53778-8BE6-4599-946A-5300B55EA0D4Q34975989-5CDFC463-EB4E-40B5-BACE-7F4FCAD9D338Q34987722-7CF5B3F9-4A98-40C4-8D58-B7306C02DD6EQ34996877-3F8240ED-4FC2-45C1-A9DB-ABFE6E8C7B60Q35260544-F4A32ACA-FAF9-4468-9F30-0BD701CCB2FAQ35974690-8809A667-F606-45A1-88A9-B45D4725BAEBQ36259824-E2610CC7-A626-40A6-BBD1-04B3B6C37DDCQ36380552-21C11DF8-C9A0-4D65-B906-99B1DA35E759Q36530398-328E61E7-EFDA-4398-9C55-78ED1CAABD3FQ36831221-C80B4EFB-6CBE-46C1-9759-C086DB5DEA8AQ37016175-623C262E-7C95-47FC-BEFE-6A24A991BBE1Q37117293-848C194E-611B-483C-AAD1-CCCCF144D2EDQ37459800-BCF0D3F3-2A63-4806-B82F-C11455F3DE80Q37626627-9EDA042D-969D-4F70-BBB7-CE86CCE290D6Q37854837-42FDEECA-F71E-4CB5-89C2-803911E4FD13Q38070363-FB48416C-A387-487B-B606-C153E3A40EFCQ38078816-EF406982-A7B9-4398-8B3C-1DF9B7E1C055Q38112269-302158D9-59D9-4F5B-86F6-22C93B38ADE3
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lise L Gluud
@ast
Lise L Gluud
@en
Lise L Gluud
@es
Lise L Gluud
@nl
Lise L Gluud
@sl
type
label
Lise L Gluud
@ast
Lise L Gluud
@en
Lise L Gluud
@es
Lise L Gluud
@nl
Lise L Gluud
@sl
prefLabel
Lise L Gluud
@ast
Lise L Gluud
@en
Lise L Gluud
@es
Lise L Gluud
@nl
Lise L Gluud
@sl
P106
P21
P31
P496
0000-0002-9462-4468